SEARCH

SEARCH BY CITATION

References

  • 1
    Arruda, V., Von-Zuben, P., Chiaparini, L., Annichino-Bizzacchi, J., Costa, F. (1997) The mutation Ala677Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis. Thrombosis and Haemostasis, 77, 818 821.
  • 2
    Brown, K., Williamson, D., Luddington, R., Baker, P., Baglin, T. (1997) Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3′-untranslated region of the prothrombin gene. British Journal of Haematology, 98, 907 909.
  • 3
    Brugada, R. & Marian, A. (1997) A common mutation in methylenetetrahydrofolate reductase gene is not a major risk of coronary artery disease or myocardial infarction. Athersclerosis, 128, 107 112.
  • 4
    Cattaneo, M., Tsai, M., Bucciarelli, P., Taioli, E., Bignell, M., Mannucci, P. (1997) A common mutation in the methylenetetrahydrofolate reductase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant factor V (factor V: Q506). Arteriosclerosis Thrombosis and Vascular Biology, 17, 1662 1666.
  • 5
    Den-Heijer, M., Koster, T., Blom, H., Bos, G., Briet, E., Reitsma, P., Vandenbroucke, J., Rosendaal, F. (1996) Hyperhomocysteinaemia as a risk factor for deep-vein thrombosis. New England Journal of Medicine, 334, 759 762.
  • 6
    Frosst, P., Blom, H., Milos, R., Goyette, P., Sheppard, C., Mathews, R., Boers, G., Den Heijer, M., Kluijtmans, L., Van Den Heuvel, L., Rozen, R. (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nature Genetics, 10, 111 113.
  • 7
    Ma, J., Stampfer, M., Hennekens, C., Frosst, P., Selhub, J., Horsford, J., Malinow, M., Willett, W., Rozen, R. (1996) Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation, 94, 2410 2416.
  • 8
    Nygard, O., Nordrehaug, J., Refsum, H., Ueland, P., Farstad, M., Vollset, S. (1997) Plasma homocysteine levels and mortality in patients with coronary artery disease. New England Journal of Medicine, 337, 230 236.
  • 9
    Salden, A., Keeney, S., Hay, C., Cumming, A. (1997) The C677T MTHFR variant and the risk of venous thrombosis. (Letter). British Journal of Haematology, 99, 472.
  • 10
    Simioni, P., Prandoni, P., Burlina, A., Tormene, D., Sardella, C., Ferrari, V., Benedetti, L., Girolami, A. (1996) Hyperhomocysteinaemia and deep-vein thrombosis. Thrombosis and Haemostasis, 76, 883 886.
  • 11
    Tosetto, A., Missiaglia, E., Frezzato, M., Rodeghiero, F. (1997) The VITA project: C677T mutation in the methylene-tetrahydrofolate reductase gene and risk of venous thromboembolism. British Journal of Haematology, 97, 804 806.
  • 12
    Van-Bockxmeer, F., Mamotte, C., Vasikaran, S., Taylor, R. (1997) Methylenetetrahydrofolate reductase gene and coronary artery disease. Circulation, 95, 21 23.